United Parcel Service is undergoing a business overhaul. General Mills appears to be an opportunity for value investors.
Ameriprise Financial Inc. trimmed its holdings in shares of Medtronic PLC (NYSE: MDT) by 5.7% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Com
Ardsley Advisory Partners LP bought a new position in Medtronic PLC (NYSE: MDT) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (
Medtronic is regaining momentum, driven by double-digit growth in key cardiac franchises and a raised full-year revenue outlook. MDT's pulsed-field ablation business surged, with U.S. PFA sales more t
NEW HOPE, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact t

3 No-Brainer Dividend Stocks to Buy Right Now

11:15pm, Sunday, 07'th Dec 2025
Enterprise Products Partners will produce significantly more free cash flow in 2026. Medtronic is only two years away from achieving a rare dividend milestone.
Medtronic is a solid choice for dividend investors, but Intuitive Surgical is a better option for growth-oriented investors. Intuitive Surgical will continue dominating its niche even as Medtronic ent
Brown Advisory Inc. lowered its position in shares of Medtronic PLC (NYSE: MDT) by 3.7% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 272,4

Medtronic (MDT) Upgraded to Buy: Here's Why

01:01pm, Friday, 05'th Dec 2025
Medtronic (MDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best option f
Medtronic gains from the FDA clearance of its Hugo RAS system, expanding U.S. access to robotic-assisted urologic surgery.
GALWAY, Ireland , Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal
Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage for expected sales growth in 2026.
Things are finally looking up for the company.
Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future. GALWAY
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE